Stockscreener 앱 받기
47.11
2.95%
1.35
전일 마감가:
$45.76
열려 있는:
$45.92
하루 거래량:
550.45K
Relative Volume:
0.77
시가총액:
$2.28B
수익:
$656.32M
순이익/손실:
$-164.17M
주가수익비율:
-90.60
EPS:
-0.52
순현금흐름:
$40.93M
1주 성능:
+5.51%
1개월 성능:
+15.27%
6개월 성능:
-7.52%
1년 성능:
-17.57%
1일 변동 폭
$45.92
$47.49
1주일 범위
$44.41
$47.49
52주 변동 폭
$38.82
$69.16
Azenta Inc Stock (AZTA) Company Profile
명칭
Azenta Inc
전화
(978) 262-2400
주소
200 SUMMIT DRIVE, BURLINGTON
AZTA을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
AZTA
Azenta Inc
|
47.11 | 2.28B | 656.32M | -164.17M | 40.93M | -0.52 |
|
ISRG
Intuitive Surgical Inc
|
538.55 | 192.83B | 7.87B | 2.24B | 586.00M | 4.25 |
|
BDX
Becton Dickinson Co
|
221.98 | 64.77B | 20.18B | 1.73B | 3.07B | 5.51 |
|
ALC
Alcon Inc
|
88.23 | 43.75B | 9.76B | 1.16B | 665.00M | 0.72 |
|
RMD
Resmed Inc
|
249.33 | 36.84B | 4.81B | 1.11B | 1.35B | 6.16 |
|
WST
West Pharmaceutical Services Inc
|
323.32 | 23.33B | 2.88B | 499.60M | 321.60M | 7.41 |
Azenta Inc Stock (AZTA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-04-04 | 개시 | Jefferies | Hold |
| 2024-02-01 | 재확인 | B. Riley Securities | Buy |
| 2023-07-19 | 개시 | Raymond James | Mkt Perform |
| 2023-05-10 | 다운그레이드 | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2023-02-09 | 다운그레이드 | Stephens | Overweight → Equal-Weight |
| 2023-01-03 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2022-03-31 | 재개 | B. Riley Securities | Buy |
| 2022-03-21 | 개시 | Evercore ISI | Outperform |
모두보기
Azenta Inc 주식(AZTA)의 최신 뉴스
Azenta Inc. (AZTA) reports earnings - Quartzy
Azenta (FRA:BA3) Debt-to-EBITDA : 1.79 (As of Jun. 2024) - GuruFocus.com
Azenta's SVP sells shares worth $45,639 By Investing.com - Investing.com Canada
Azenta's CFO Herman Cueto sells $28,529 in stock - Investing.com India
B. Metzler seel. Sohn & Co. Holding AG Takes Position in Azenta, Inc. (NASDAQ:AZTA) - MarketBeat
Azenta SVP Wang sells $13,944 in stock By Investing.com - Investing.com Nigeria
Azenta SVP Wang sells $13,944 in stock - Investing.com India
Azenta's SVP sells shares worth $45,639 - Investing.com
Azenta's CFO Herman Cueto sells $28,529 in stock By Investing.com - Investing.com Australia
Azenta's SVP and CHRO Olga Pirogova sells shares worth $21,958 By Investing.com - Investing.com Australia
Azenta's SVP and CHRO Olga Pirogova sells shares worth $21,958 - Investing.com
Azenta to Participate in Stephens Annual Investment Conference - GuruFocus.com
Azenta, Inc. (NASDAQ:AZTA) Shares Sold by Ontario Teachers Pension Plan Board - MarketBeat
Principal Financial Group Inc. Sells 67,809 Shares of Azenta, Inc. (NASDAQ:AZTA) - MarketBeat
Premier Fund Managers Ltd Makes New Investment in Azenta, Inc. (NASDAQ:AZTA) - MarketBeat
Director Didier Hirsch Acquires Additional Shares of Azenta Inc (AZTA) - GuruFocus.com
Natixis Advisors LLC Sells 18,668 Shares of Azenta, Inc. (NASDAQ:AZTA) - MarketBeat
Flex Set to Join S&P MidCap 400; Azenta and Concentra Group Holdings to Join S&P SmallCap 600 - Yahoo Finance
Azenta director Martin Madaus purchases $201,403 in company stock - Investing.com
Azenta director Martin Madaus purchases $201,403 in company stock By Investing.com - Investing.com UK
Azenta Obtains Regulatory Approval for Clinical Long-Read Whole Genome Sequencing Test - Technology Networks
Azenta (NASDAQ:AZTA) Sets New 1-Year LowWhat's Next? - MarketBeat
Azenta, Inc. (NASDAQ:AZTA) Sees Significant Drop in Short Interest - MarketBeat
Analysts Have Just Cut Their Azenta, Inc. (NASDAQ:AZTA) Revenue Estimates By 14% - Simply Wall St
Azenta, Inc. (NASDAQ:AZTA) Analysts Just Slashed This Year's Revenue Estimates By 14% - Yahoo Finance
Azenta, Inc. (NASDAQ:AZTA) Analysts Are Cutting Their Estimates: Here's What You Need To Know - Yahoo Finance
Royce & Associates LP Increases Position in Azenta, Inc. (NASDAQ:AZTA) - MarketBeat
Azenta Inc (AZTA) Trading Down 3.84% on Nov 14 - GuruFocus.com
Azenta to Participate in Stephens Annual Investment Conference – Company Announcement - Financial Times
Azenta shares target trimmed by Evercore ISI amid challenging macro - Investing.com India
Azenta Full Year 2024 Earnings: EPS Misses Expectations - Yahoo Finance
Shareholders Should Be Pleased With Azenta, Inc.'s (NASDAQ:AZTA) Price - Simply Wall St
Finansavisen - Finansavisen
Kayne Anderson Rudnick Investment Management LLC's Strategic Red - GuruFocus.com
Biobanking Market to Reach Market Valuation of USD 95.5 Billion by 2031 | SkyQuest Technology - GlobeNewswire Inc.
Azenta (NASDAQ:AZTA) Posts Earnings Results, Beats Expectations By $0.08 EPS - MarketBeat
Azenta (NASDAQ:AZTA) Given New $55.00 Price Target at Needham & Company LLC - MarketBeat
Azenta, Inc. (NASDAQ:AZTA) Q4 2024 Earnings Call Transcript - Insider Monkey
Earnings call: Azenta reports mixed FY 2024 results, plans B Medical sale - Investing.com UK
Azenta Inc (AZTA) Q4 2024 Earnings Call Highlights: Navigating M - GuruFocus.com
Azenta reports modest growth and portfolio streamlining By Investing.com - Investing.com Australia
Azenta (AZTA) Q4 Earnings Top Estimates - MSN
Azenta Inc (AZTA) Q4 2024 Earnings Call Highlights: Navigating Market Challenges with Strategic ... - Yahoo Finance
Azenta, Inc. Reveals Strategic Portfolio Streamlining - TipRanks
Azenta, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended September 30, 2024 - Marketscreener.com
Azenta Appoints New CFO Amid Revenue Growth - TipRanks
Azenta Inc (AZTA) Q4 2024 Earnings: Revenue at $170M Beats Estimates, Reports GAAP EPS Loss of $0.10 - GuruFocus.com
Brooks: Fiscal Q4 Earnings Snapshot - Marketscreener.com
Azenta reports modest growth and portfolio streamlining - Investing.com India
Azenta Reports Fourth Quarter and Full Year Fiscal 2024 Results; Announces the Plan to Sell B Medical Systems and Appoints Lawrence Y. Lin as CFO - PR Newswire
WCM Investment Management LLC Cuts Stock Holdings in Azenta, Inc. (NASDAQ:AZTA) - MarketBeat
Azenta Inc (AZTA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Azenta Inc 주식 (AZTA) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Hughes Violetta | VP, Chief Accounting Officer |
Nov 19 '24 |
Sale |
40.07 |
163 |
6,531 |
9,920 |
| Zhou Ginger | SVP and General Manager, Genom |
Nov 19 '24 |
Sale |
40.07 |
491 |
19,674 |
27,499 |
| Wang David Dong | SVP & GM, SMS |
Nov 19 '24 |
Sale |
40.07 |
348 |
13,944 |
24,114 |
| Joseph Jason | SVP, General Counsel, Secy. |
Nov 19 '24 |
Sale |
40.07 |
1,139 |
45,640 |
112,564 |
| Cueto Herman | EVP, Chief Financial Officer |
Nov 19 '24 |
Sale |
40.07 |
712 |
28,530 |
23,892 |
| Marotta John | President and CEO |
Nov 18 '24 |
Buy |
39.48 |
12,717 |
502,066 |
99,612 |
| Marotta John | President and CEO |
Nov 19 '24 |
Buy |
40.67 |
1,250 |
50,838 |
100,862 |
| Cornog William L | Director |
Nov 18 '24 |
Buy |
39.60 |
12,500 |
495,000 |
14,755 |
| HIRSCH DIDIER | Director |
Nov 18 '24 |
Buy |
39.50 |
1,000 |
39,500 |
3,465 |
| Madaus Martin D | Director |
Nov 19 '24 |
Buy |
40.77 |
4,940 |
201,404 |
7,405 |
0.14%
자본화:
|
볼륨(24시간):